Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Vaccines (Basel) · 2022 · PMC9144569 · PMID 35632424

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

To address this, we undertook subgroup analysis according to these factors identified, which suggests there may be significant effect moderation due to vaccine and disease type but not age.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.